OXYTOCIN APX oxytocin 10 IU/1 mL solution for injection ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

oxytocin apx oxytocin 10 iu/1 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: acetic acid; chlorobutanol hemihydrate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Midazolam-Baxter midazolam (as hydrochloride) 5mg/1 mL solution for injection ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

midazolam-baxter midazolam (as hydrochloride) 5mg/1 ml solution for injection ampoule

baxter healthcare pty ltd - midazolam, quantity: 5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections; nitrogen - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

OXYTOCIN GH Solution for Injection 10 IU/1 mL ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

oxytocin gh solution for injection 10 iu/1 ml ampoule

generic health pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

OXYTOCIN GH Solution for Injection 5 IU/ 1 mL ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

oxytocin gh solution for injection 5 iu/ 1 ml ampoule

generic health pty ltd - oxytocin, quantity: 5 iu/ml - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium chloride; glacial acetic acid - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

POR-8 FERRING ornipressin 5 I.U./mL injection ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

por-8 ferring ornipressin 5 i.u./ml injection ampoule

ferring pharmaceuticals pty ltd - ornipressin, quantity: 5 iu/ml - injection, solution - excipient ingredients: sodium acetate; glacial acetic acid; sodium chloride; water for injections - local administration: to induce ischaemia and haemostasis at the site of an operation in various types of surgery where bleeding is a problem plastic surgery: hair transplants, meloplasty, otoplasty, skin grafts, resection of tumours etc obstetrics/gynaecology: vaginal repair, vaginal hysterectomy, cone biopsy of cervix, episiotomy, myomectomy. ent surgery: tonsillectomy, submucous resection of septum, myringoplasty etc. other types of surgery: neurosurgery, orofacial surgery, surgery of head and neck, abdominal and rectal surgery, care of burns (excision of eschar).

Pfizer (Australia) MIDAZOLAM INJECTION midazolam 5mg/1mL injection ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pfizer (australia) midazolam injection midazolam 5mg/1ml injection ampoule

pfizer australia pty ltd - midazolam, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - intravenously as an agent for: conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy,coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid. induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be obtained with a narrower dose range and in a shorter period of time. intermittent intravenous administration or continuous infusion for: sedation in intensive care units. intramuscularly for: preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

DBL GENTAMICIN 10mg/1mL(as sulfate) Injection Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

dbl gentamicin 10mg/1ml(as sulfate) injection

pfizer australia pty ltd - gentamicin sulfate, quantity: 16.13 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; sulfuric acid; sodium hydroxide - indications as at 31 october 2003: gentamicin injection is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa, proteus species (indole positive and indole negative), escherichia coli, klebsiella - enterobacter - serratia species, staphylococcus species (coagulase positive and coagulase negative). gentamicin injection should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia, respiratory tract infections, infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis, urinary tract infections (recurrent, complicated). gentamicin injection is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. gentamicin injection may be considered as initial therapy in suspected or confirmed gram negative infections and ther

DBL EPHEDRINE SULFATE 30mg/1mL Injection Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

dbl ephedrine sulfate 30mg/1ml injection

pfizer australia pty ltd - ephedrine sulfate, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - ephedrine is indicated in the treatment of shock unresponsive to fluid replacement. it is also indicated in the treatment of hypotension secondary to spinal anaesthesia. ephedrine sulfate injection has also been used in the treatment of bronchial asthma and reversible bronchospasm although more selective agents (beta adrenergic agonists) are now available.